You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Camostat mesylate

Showing 1 - 25 of 514
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fontan Operation, Protein-Losing Enteropathy, Camostat Mesylate Trial (Camostat mesylate)

Not yet recruiting
  • Fontan Operation
  • +2 more
  • Camostat mesylate
  • (no location specified)
Jul 23, 2022

COVID-19 Trial in New Haven (Camostat Mesilate, Placebo)

Completed
Has Results
  • COVID-19
  • Camostat Mesilate
  • Placebo
  • New Haven, Connecticut
    Yale University
Mar 22, 2022

Covid19 Trial in France (Camostat Mesylate, Placebo)

Terminated
  • Covid19
  • Camostat Mesylate
  • Placebo
  • Argenteuil, France
  • +5 more
Jan 27, 2022

Corona Virus Infection, SARS-CoV-2 Infection, SARS-CoV-2 PCR Test Positive Trial in Germany (biological, drug, other)

Completed
  • Corona Virus Infection
  • +3 more
  • Convalescent plasma
  • +3 more
  • Freiburg im Breisgau, Baden-Württemberg, Germany
  • +5 more
Feb 9, 2022

Healthy Trial in Daejeon (DWJ1248)

Recruiting
  • Healthy
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Mar 1, 2021

COVID-19 Trial in United States (Camostat Mesilate, Placebo)

Completed
Has Results
  • COVID-19
  • Camostat Mesilate
  • Placebo
  • Palm Springs, California
  • +20 more
Jan 13, 2022

COVID - 19 Trial in Ramat Gan, Tel HaShomer (hydroxychloroquine in combination with camostat mesylate, Hydroxychloroquine in

Unknown status
  • COVID - 19
  • hydroxychloroquine in combination with camostat mesylate
  • Hydroxychloroquine in combination of Azithromycin
  • Ramat Gan, Israel
  • +1 more
Apr 20, 2020

COVID Trial (Camostat Mesilate, Placebo, Hydroxychloroquine)

Withdrawn
  • COVID
  • Camostat Mesilate
  • +2 more
  • (no location specified)
Dec 17, 2020

Severe COVID-19 Trial in Seoul (DWJ1248 with Remdesivir, Placebo with Remdesivir)

Recruiting
  • Severe COVID-19
  • DWJ1248 with Remdesivir
  • Placebo with Remdesivir
  • Seoul, Korea, Republic of
    National Medical Center
Feb 26, 2021

Covid19, SARS-CoV Infection Trial in Leuven (Camostat, Placebo)

Terminated
  • Covid19
  • SARS-CoV Infection
  • Leuven, Belgium
    KU Leuven
Sep 29, 2022

Multiple Myeloma Trial in Houston (Belumosudil mesylate)

Not yet recruiting
  • Multiple Myeloma
  • Belumosudil mesylate
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2023

Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Canada, United States (Dasatinib, Imatinib Mesylate, Laboratory

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Burbank, California
  • +340 more
Jan 28, 2023

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease Trial in United States (drug, other,

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Minimal Residual Disease
  • Goodyear, Arizona
  • +237 more
Jan 3, 2023

Gastrointestinal Stromal Tumor of Rectum Trial in Fuzhou (Imatinib Mesylate, Local resection)

Not yet recruiting
  • Gastrointestinal Stromal Tumor of Rectum
  • Imatinib Mesylate
  • Local resection
  • Fuzhou, Fujian, China
    Weizhong Jiang
Jul 23, 2023

Hyperpigmentation, Post-inflammatory Hyperpigmentation, Acne Trial (Topical Cetyl Tranexamate Mesylate)

Not yet recruiting
  • Hyperpigmentation
  • +2 more
  • Topical Cetyl Tranexamate Mesylate
  • (no location specified)
Oct 6, 2023

Covid19, SARS-CoV Infection, Coronavirus Infection Trial in Baltimore (Camostat Mesilate, Bicalutamide 150 mg)

Terminated
  • Covid19
  • +2 more
  • Camostat Mesilate
  • Bicalutamide 150 mg
  • Baltimore, Maryland
    Johns Hopkins Hospital
Sep 15, 2021

Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)

Recruiting
  • Immunotherapy
  • Gastrict Cancer
  • Fuzhou, China
    Fujian cancer hospital
Jan 17, 2023

Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)

Not yet recruiting
  • Immunotherapy Gastrict Cancer
  • (no location specified)
Jan 17, 2023

Breast Cancer Trial in United States (gemcitabine HCl, imatinib mesylate)

Terminated
Has Results
  • Breast Cancer
  • gemcitabine hydrochloride
  • imatinib mesylate
  • Chicago, Illinois
  • +8 more
Aug 12, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8

Terminated
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Eribulin Mesylate
  • Houston, Texas
  • +1 more
Oct 27, 2022

Healthy Volunteers Trial in Berlin (Niclosamide, Placebo)

Completed
  • Healthy Volunteers
  • Berlin, Germany
    Charité Research Organisation GmbH
Nov 26, 2021

HIV Trial in San Diego (Cenicriviroc Mesylate (CVC), Placebo)

Withdrawn
  • HIV Infections
  • Cenicriviroc Mesylate (CVC)
  • Placebo
  • (no location specified)
Dec 19, 2022

Cholangiocarcinoma Trial (Carrilizumab, Albumin-bound paclitaxel, Apatinib)

Not yet recruiting
  • Cholangiocarcinoma
  • (no location specified)
Dec 9, 2022

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Esophageal Cancer by AJCC V8 Stage Trial in Zhengzhou (Camrelizumab+Apatinib+Chemotherapy?Camrelizumab+Apatinib,

Recruiting
  • Esophageal Cancer by AJCC V8 Stage
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Feb 12, 2023